This study will explore information on whether changing the salt formulation of indacaterol affects the incidence of post-inhalation cough.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Presence of cough within 5 minutes post dose and the onset of cough (relative to inhalation)
Timeframe: throughout the study
Severity of cough: to be judged independently by both the patient and the physician
Timeframe: throughout the study
Occurrence of cough within 1 minute post dose
Timeframe: throughout the study
Number of coughs
Timeframe: throughout the study
Duration of coughing
Timeframe: throughout the study